1	[	[	O	(	O	6	NMOD
2	Changes	Change	B-NP	NNS	O	6	NMOD
3	of	of	B-PP	IN	O	2	NMOD
4	pathogens	pathogen	B-NP	NNS	O	3	PMOD
5	and	and	O	CC	O	6	NMOD
6	susceptibility	susceptibility	B-NP	NN	O	0	ROOT
7	to	to	B-PP	TO	O	6	NMOD
8	antibiotics	antibiotic	B-NP	NNS	O	7	PMOD
9	in	in	B-PP	IN	O	8	NMOD
10	hematology	hematology	B-NP	NN	O	11	NMOD
11	ward	ward	I-NP	NN	O	9	PMOD
12	from	from	B-PP	IN	O	11	NMOD
13	years	year	B-NP	NNS	O	12	PMOD
14	2001	2001	B-NP	CD	O	16	AMOD
15	to	to	B-PP	TO	O	16	AMOD
16	2005	2005	B-NP	CD	O	13	NMOD
17	]	]	O	)	O	6	NMOD
18	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	purpose	purpose	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	this	this	B-NP	DT	O	5	NMOD
5	study	study	I-NP	NN	O	3	PMOD
6	was	be	B-VP	VBD	O	0	ROOT
7	to	to	B-VP	TO	O	8	VMOD
8	determine	determine	I-VP	VB	O	6	PRD
9	the	the	B-NP	DT	O	10	NMOD
10	changes	change	I-NP	NNS	O	20	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	pathogens	pathogen	B-NP	NNS	O	11	PMOD
13	in	in	B-PP	IN	O	10	NMOD
14	hematological	hematological	B-NP	JJ	O	15	NMOD
15	ward	ward	I-NP	NN	O	17	NMOD
16	and	and	O	CC	O	17	NMOD
17	susceptibility	susceptibility	B-NP	NN	O	13	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	patients	patient	B-NP	NNS	O	18	PMOD
20	received	receive	B-VP	VBD	O	8	VMOD
21	chemotherapy	chemotherapy	B-NP	NN	O	20	OBJ
22	to	to	B-PP	TO	O	21	NMOD
23	antibiotics	antibiotic	B-NP	NNS	O	22	PMOD
24	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	2	NMOD
2	pathogens	pathogen	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	taken	take	I-VP	VBN	O	10	NMOD
5	from	from	B-PP	IN	O	4	VMOD
6	blood	blood	B-NP	NN	O	5	PMOD
7	,	,	O	,	O	10	P
8	urine	urine	B-NP	NN	O	10	NMOD
9	and	and	O	CC	O	10	NMOD
10	sputum	sputum	B-NP	NN	O	3	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	patients	patient	B-NP	NNS	O	11	PMOD
13	who	who	B-NP	WP	O	12	NMOD
14	accepted	accept	B-VP	VBD	O	13	SBAR
15	chemotherapy	chemotherapy	B-NP	NN	O	14	OBJ
16	from	from	B-PP	IN	O	14	VMOD
17	years	year	B-NP	NNS	O	16	PMOD
18	2001	2001	B-NP	CD	O	20	NMOD
19	to	to	B-PP	TO	O	20	NMOD
20	2005	2005	B-NP	CD	O	17	NMOD
21	,	,	O	,	O	3	P
22	then	then	B-ADVP	RB	O	3	VMOD
23	were	be	B-VP	VBD	O	3	VMOD
24	isolated	isolate	I-VP	VBN	O	23	VC
25	and	and	I-VP	CC	O	24	VMOD
26	identified	identify	I-VP	VBN	O	24	VMOD
27	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	susceptibility	susceptibility	I-NP	NN	O	3	NMOD
3	test	test	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	performed	perform	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	disk	disk	B-NP	NN	O	9	NMOD
8	diffusion	diffusion	I-NP	NN	O	9	NMOD
9	method	method	I-NP	NN	O	6	PMOD
10	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	2	NMOD
2	results	result	I-NP	NNS	O	3	SUB
3	showed	show	B-VP	VBD	O	0	ROOT
4	that	that	B-SBAR	IN	O	3	VMOD
5	the	the	B-NP	DT	O	6	NMOD
6	total	total	I-NP	NN	O	10	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	418	418	B-NP	CD	O	9	NMOD
9	strains	strain	I-NP	NNS	O	7	PMOD
10	were	be	B-VP	VBD	O	4	SBAR
11	detected	detect	I-VP	VBN	O	10	VC
12	.	.	O	.	O	3	P

1	Gram-negative	Gram-negative	B-NP	JJ	O	2	NMOD
2	bacteria	bacteria	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	the	the	B-NP	DT	O	6	NMOD
5	most	most	I-NP	RBS	O	6	AMOD
6	common	common	I-NP	JJ	O	3	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	nosocomial	nosocomial	B-NP	JJ	O	9	NMOD
9	infection	infection	I-NP	NN	O	7	PMOD
10	.	.	O	.	O	3	P

1	Pseudomonas	Pseudomonas	B-NP	NNP	O	2	NMOD
2	aeruginosa	aeruginosa	I-NP	NNP	O	9	SUB
3	,	,	O	,	O	9	P
4	Enterobacter	Enterobacter	B-NP	NNP	O	5	NMOD
5	cloacae	cloaca	I-NP	NNS	O	9	SUB
6	,	,	O	,	O	8	P
7	E.	E.	B-NP	FW	O	8	NMOD
8	coli	coli	I-NP	FW	O	5	NMOD
9	account	account	B-VP	VBP	O	0	ROOT
10	for	for	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	most	most	I-NP	JJS	O	20	SUB
13	of	of	B-PP	IN	O	12	NMOD
14	Gram	Gram	B-NP	NNP	O	17	NMOD
15	negative-	negative-	I-NP	JJ	O	17	NMOD
16	bacteria	bacteria	I-NP	NNS	O	17	NMOD
17	infection	infection	I-NP	NN	O	13	PMOD
18	and	and	O	CC	O	20	AMOD
19	most	most	B-ADJP	RBS	O	20	AMOD
20	resistant	resistant	I-ADJP	JJ	O	10	PMOD
21	to	to	B-PP	TO	O	20	AMOD
22	broad-spectrum	broad-spectrum	B-NP	NN	B-protein	23	NMOD
23	penicillin	penicillin	I-NP	NN	I-protein	26	NMOD
24	,	,	O	,	O	26	P
25	Acinetobacter	Acinetobacter	B-NP	NNP	O	26	NMOD
26	baumannii	baumannii	I-NP	NN	O	21	PMOD
27	showed	show	B-VP	VBD	O	9	VMOD
28	a	a	B-NP	DT	O	29	NMOD
29	trend	trend	I-NP	NN	O	27	OBJ
30	of	of	B-PP	IN	O	29	NMOD
31	increase	increase	B-NP	NN	O	30	PMOD
32	.	.	O	.	O	9	P

1	The	The	B-NP	DT	O	2	NMOD
2	ratios	ratio	I-NP	NNS	O	9	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	gram	gram	B-NP	NN	O	6	NMOD
5	positive	positive	I-NP	JJ	O	6	NMOD
6	bacteria	bacteria	I-NP	NNS	O	8	NMOD
7	and	and	I-NP	CC	O	8	NMOD
8	fungi	fungus	I-NP	NNS	O	3	PMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	increased	increase	I-VP	VBN	O	9	VC
11	slowly	slowly	B-ADVP	RB	O	10	VMOD
12	,	,	O	,	O	10	P
13	mainly	mainly	B-ADVP	RB	O	10	VMOD
14	as	as	B-SBAR	IN	O	10	VMOD
15	Enterococcus	Enterococcus	B-NP	NNP	O	17	NMOD
16	and	and	I-NP	CC	O	17	NMOD
17	Candida	Candida	I-NP	NNP	O	14	SBAR
18	.	.	O	.	O	9	P

1	Enterococcus	Enterococcus	B-NP	NNP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	the	the	B-NP	DT	O	6	NMOD
4	most	most	I-NP	RBS	O	5	AMOD
5	common	common	I-NP	JJ	O	6	NMOD
6	cause	cause	I-NP	NN	O	2	PRD
7	of	of	B-PP	IN	O	6	NMOD
8	Gram-positive	Gram-positive	B-NP	JJ	O	10	NMOD
9	bacterial	bacterial	I-NP	JJ	O	10	NMOD
10	infection	infection	I-NP	NN	O	7	PMOD
11	.	.	O	.	O	2	P

1	Vancomycin	Vancomycin	B-NP	NN	O	2	NMOD
2	resistance	resistance	I-NP	NN	O	3	SUB
3	did	do	B-VP	VBD	O	0	ROOT
4	not	not	I-VP	RB	O	3	VMOD
5	occur	occur	I-VP	VB	O	3	VC
6	.	.	O	.	O	3	P

1	It	It	B-NP	PRP	O	2	SUB
2	is	be	B-VP	VBZ	O	0	ROOT
3	concluded	conclude	I-VP	VBN	O	2	VC
4	that	that	B-SBAR	IN	O	3	VMOD
5	Gram-negative	Gram-negative	B-NP	JJ	O	6	NMOD
6	bacteria	bacteria	I-NP	NNS	O	7	SUB
7	are	be	B-VP	VBP	O	4	SBAR
8	main	main	B-NP	JJ	O	9	NMOD
9	cause	cause	I-NP	NN	O	7	PRD
10	of	of	B-PP	IN	O	9	NMOD
11	nosocomial	nosocomial	B-NP	JJ	O	12	NMOD
12	infection	infection	I-NP	NN	O	10	PMOD
13	in	in	B-PP	IN	O	9	NMOD
14	patients	patient	B-NP	NNS	O	13	PMOD
15	with	with	B-PP	IN	O	14	NMOD
16	hematological	hematological	B-NP	JJ	O	17	NMOD
17	malignancies	malignancy	I-NP	NNS	O	15	PMOD
18	.	.	O	.	O	2	P

1	Gram	Gram	B-NP	NN	O	3	NMOD
2	positive	positive	I-NP	JJ	O	3	NMOD
3	bacteria	bacteria	I-NP	NNS	O	5	NMOD
4	and	and	I-NP	CC	O	5	NMOD
5	fungi	fungus	I-NP	NNS	O	6	SUB
6	had	have	B-VP	VBD	O	0	ROOT
7	been	be	I-VP	VBN	O	6	VC
8	more	more	B-ADJP	RBR	O	9	AMOD
9	frequent	frequent	I-ADJP	JJ	O	7	PRD
10	.	.	O	.	O	6	P

1	Strains	Strain	B-NP	NNS	O	6	SUB
2	resistant	resistant	B-ADJP	JJ	O	1	NMOD
3	to	to	B-PP	TO	O	2	AMOD
4	antimicrobial	antimicrobial	B-NP	JJ	O	5	NMOD
5	agents	agent	I-NP	NNS	O	3	PMOD
6	increase	increase	B-VP	VBP	O	0	ROOT
7	.	.	O	.	O	6	P

